Breaking News
Sort by:
Top Post
Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]
Breakthrough Radiology AI Provider Annalise.ai Appoints Proven Global Healthcare Leader as CEO, Officially Launches US Team Following FDA Clearances
annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today […]
World’s First Chemo Drone Delivery Announced on NHS Birthday
NHS cancer patients will be the first in the world to benefit from chemotherapy delivered […]
Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies
Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired […]
VistaPath Raises $4M to Modernize Pathology Labs Using Computer Vision and Artificial Intelligence
VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that […]
Regard Raises $15.3 Million Series A to Accurately and Quickly Uncover Patient Diagnoses
Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians […]
Englewood Health Introduces Robot-Assisted Spine Surgery with GPS-like Precision to New Jersey
Englewood Health has become the first hospital in New Jersey and one of only 20 hospitals in […]
BioMech, ēlizur Announce Partnership Integrating AI-enabled Motion Analytics into Physical Therapy Solution
BioMech Health, a division of BioMech Holdings, LLC, and ēlizur, a leading musculoskeletal solutions provider, announced today a […]
FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF
FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell […]
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, […]
Optibrium Receives Further Investment From Kester Capital
Optibrium™, a developer of software for drug discovery, today announced it has secured further investment […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more